To study the anti-cancer effect of EGFR inhibitors Cilen/PP in EGFR-resistant integrin αvβ3+ NSCLC cells, the integrin αvβ3+ A549 cells were inoculated in nude mice to establish the EGFR inhibitors resistant tumor model. The gene discussed is EGFR; the disease is cancer.